Systematic Financial Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Systematic Financial Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-120,410	Closed	-$340K	–	578
2020 Q1	$340K	Sell	120,410 -32,610	-21%	-$105K	0.02%	275
2019 Q4	$497K	Sell	153,020 -97,915	-39%	-$284K	0.02%	415
2019 Q3	$542K	Sell	250,935 -22,490	-8%	-$60.1K	0.02%	347
2019 Q2	$859K	Sell	273,425 -84,555	-24%	-$274K	0.03%	422
2019 Q1	$1.33M	Sell	357,980 -59,220	-14%	-$200K	0.05%	319
2018 Q4	$1.21M	Sell	417,200 -186,260	-31%	-$512K	0.04%	310
2018 Q3	$1.59M	Buy	603,460 +107,610	+22%	+$264K	0.04%	304
2018 Q2	$1.16M	Sell	495,850 -71,945	-13%	-$201K	0.03%	527
2018 Q1	$1.67M	Sell	567,795 -32,730	-5%	-$89.3K	0.04%	289
2017 Q4	$1.65M	Buy	600,525 +101,695	+20%	+$312K	0.03%	315
2017 Q3	$1.69M	Sell	498,830 -215,810	-30%	-$600K	0.03%	312
2017 Q2	$1.76M	Buy	714,640 +2,585	+0.4%	+$5.95K	0.03%	401
2017 Q1	$1.62M	Sell	712,055 -1,030	-0.1%	-$2.28K	0.03%	482
2016 Q4	$1.51M	Buy	713,085 +176,360	+33%	+$492K	0.02%	547
2016 Q3	$1.8M	Sell	536,725 -54,770	-9%	-$174K	0.03%	387
2016 Q2	$1.86M	Buy	591,495 +119,545	+25%	+$399K	0.03%	358
2016 Q1	$1.57M	Buy	471,950 +1,450	+0.3%	+$4.52K	0.02%	460
2015 Q4	$1.67M	Buy	470,500 +64,580	+16%	+$270K	0.02%	444
2015 Q3	$2.04M	Buy	405,920 +25,735	+7%	+$147K	0.02%	460
2015 Q2	$2.44M	Buy	+380,185	New	+$2.55M	0.02%	507
2014 Q1	–	Sell	-216,172	Closed	-$1.82M	–	784
2013 Q4	$1.82M	Buy	216,172 +36,760	+20%	+$310K	0.01%	535
2013 Q3	$1.43M	Sell	179,412 -6,000	-3%	-$48.2K	0.01%	548
2013 Q2	$1.43M	Buy	+185,412	New	+$1.45M	0.01%	499

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

Systematic Financial Management's PDLI Position: Q2 2020 in Review

Systematic Financial Management sold out of PDL BioPharma, Inc. (PDLI) in Q2 2020, closing a stake of 120,410 shares — an estimated $340K sold.

Systematic Financial Management first reported a position in PDLI in Q2 2013 and held it in 23 quarters. The position peaked at $2.44M in Q2 2015. 136 funds tracked by Wall St. Rank hold PDLI as of Q2 2020.

Systematic Financial Management reported no remaining PDL BioPharma, Inc. position as of Q2 2020 after selling out during the quarter.
Systematic Financial Management sold 120,410 PDL BioPharma, Inc. shares in Q2 2020, an estimated $340K.
Systematic Financial Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 23 quarters.
Systematic Financial Management's PDL BioPharma, Inc. position peaked at $2.44M in Q2 2015.
136 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2020.

Based on Systematic Financial Management's 13F filing for Q2 2020, filed 13 Aug 2020.